The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?

Published:2022-12-02 Issue:12 Volume:61 Page:1515-1516
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Carus Andreas¹^ORCID,Holmsten Karin²³,Pappot Helle⁴,Ullén Anders³⁵

Affiliation:

1. Department of Oncology, Aalborg University Hospital, Aalborg, Denmark

2. Department of Oncology, Capio Saint Göran Hospital, Stockholm, Sweden

3. Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden

4. Department of Oncology, Rigshopitalet, University Hospital of Copenhagen, Copenhagen, Denmark

5. Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Karolinska University Hospital, Solna, Sweden

Funder

Pfizer and Merck

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2022.2153620

Reference14 articles.

1. Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial

2. NUCOG (Nordic Urothelial Cancer Oncology Group). Available from: https://www.rigshospitalet.dk/nucog.

3. Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer: Three-Week Versus Four-Week Regimen

4. Bladder Cancer: Analysis of Multi–Detector Row Helical CT Enhancement Pattern and Accuracy in Tumor Detection and Perivesical Staging

5. Integrated analysis of 18F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3